Riskpilot← Back to searchSign inGet full accessSMITH & NEPHEW AS
ASActiveOrg 933183947Snarøyveien 36, 1364 FornebuWholesale of pharmaceutical and medical goods · NACE 4646Est. 198224 employees
Revenue 2024
NOK 220,3M
+15% vs 2023
EBITDA margin
6.6%
+73% vs 2023
Equity ratio
53.1%
Financial strength
Net profit 2024
NOK 12M
+77% vs 2023
| Revenue | NOK 220,3M | +15% |
| EBITDA | NOK 14,5M | +73% |
| Net profit | NOK 12M | +77% |
| Total assets | NOK 106,9M | +45% |
| Equity | NOK 56,7M | +24% |
| Employees | 24 | — |
Legal name
SMITH & NEPHEW AS
Org number
933183947
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. oktober 1982
Share capital
—
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Address
Snarøyveien 36, 1364 Fornebu
Phone
+4766842020
Email
norway@smith-nephew.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 139 535 | 155 349 | 177 283 | 191 388 | 220 265 |
| Staff expenses | −37 571 | −39 621 | −38 080 | −47 322 | −53 989 |
| EBITDA | 5 285 | 11 672 | 15 986 | 8 373 | 14 511 |
| Depreciation & amort. | −5 672 | −6 132 | −5 232 | −192 | −191 |
| EBIT | −387 | 5 539 | 10 754 | 8 181 | 14 320 |
| Net financials | −200 | −125 | 11 | 599 | 1 145 |
| Profit before tax | −587 | 5 414 | 10 765 | 8 780 | 15 465 |
| Tax | −107 | 1 224 | 2 448 | 2 015 | 3 499 |
| Net profit | −479 | 4 190 | 8 317 | 6 765 | 11 966 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 81 116 | 81 365 | 76 278 | 73 853 | 106 862 |
| Equity | 24 080 | 29 793 | 38 169 | 45 902 | 56 694 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 51 427 | 48 678 | 35 495 | 27 581 | 50 169 |
| Total debt | 51 427 | 48 678 | 35 495 | 27 581 | 50 169 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20202024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20202024
Return on equity
21.1%
This company
18.4%
Market median
+15% vs market
20202024
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20202024
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
20202024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AD Contact Person | Contact Person | 2016 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Smith & Nephew Usd Limited | Company | 100% | 100% | 2024 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SMITH & NEPHEW AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anneli Diana Charlotte Dahl | Contact Person | 0 companies |
| Magdalena Jadwiga Malkamäki | Chairman | 0 companies |
| Paul Imre Jakob Heiskanen | Chairman | 0 companies |
| Stevar Klausen | Board of Directors | 0 companies |
| Renata Monika Banasik | Chairman | 0 companies |
| Jytte Birgit Madsen | Board of Directors | 0 companies |